These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2009156)

  • 1. Special considerations for research with pharmacologic agents.
    Basmajian JV
    Am J Phys Med Rehabil; 1991 Apr; 70(2):101-6. PubMed ID: 2009156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a muscle relaxant: dantrolene sodium (Dantrium).
    Dykes MH
    JAMA; 1975 Feb; 231(8):862-4. PubMed ID: 1089167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dantrolene sodium on spasticity in multiple sclerosis.
    Gelenberg AJ; Poskanzer DC
    Neurology; 1973 Dec; 23(12):1313-5. PubMed ID: 4796610
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of dantrolene sodium and diazepam in the treatment of spasticity.
    Glass A; Hannah A
    Paraplegia; 1974 Nov; 12(3):170-4. PubMed ID: 4616209
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of dantrolene sodium and diazepam in the treatment of spasticity.
    Schmidt RT; Lee RH; Spehlmann R
    J Neurol Neurosurg Psychiatry; 1976 Apr; 39(4):350-6. PubMed ID: 778344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of Dantrium on spasticity in paraplegic and tetraplegic patients (author's transl)].
    van Laere M; Leus P; Mastelinck C
    J Belge Med Phys Rehabil; 1978; 1(2):189-99. PubMed ID: 757420
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dantrolene. Pharmacological and therapeutic aspects].
    Gerbershagen MU; Fiege M; Krause T; Agarwal K; Wappler F
    Anaesthesist; 2003 Mar; 52(3):238-45. PubMed ID: 12666006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dantrolene sodium: long-term effects in patients with muscle spasticity.
    Joynt RL
    Arch Phys Med Rehabil; 1976 May; 57(5):212-7. PubMed ID: 776122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electromyographic investigation of spasticity and muscle spasm.
    Basmajian JV
    Physiotherapy; 1976 Oct; 62(10):319-23. PubMed ID: 790427
    [No Abstract]   [Full Text] [Related]  

  • 10. Dantrolene: new indication. Cerebral palsy in children: uncertain clinical benefit.
    Prescrire Int; 2008 Dec; 17(98):237. PubMed ID: 19422149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dantrolene sodium for treatment of spasticity.
    Med Lett Drugs Ther; 1974 Jul; 16(15):61-2. PubMed ID: 4843632
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term treatment with dantrolene sodium of stroke patients with spasticity limiting the return of function.
    Ketel WB; Kolb ME
    Curr Med Res Opin; 1984; 9(3):161-9. PubMed ID: 6499510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
    Ward A; Chaffman MO; Sorkin EM
    Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acne induced by dantrolene.
    Pembroke AC; Saxena SR; Kataria M; Zilkha KD
    Br J Dermatol; 1981 Apr; 104(4):465-8. PubMed ID: 6453605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of dantrolene sodium in spasticity with low dependence on fusimotor drive.
    Knutsson E; Martensson A
    J Neurol Sci; 1976 Oct; 29(2-4):195-212. PubMed ID: 135820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.
    Pinder RM; Brogden RN; Speight TM; Avery GS
    Drugs; 1977 Jan; 13(1):3-23. PubMed ID: 318989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of spasticity: some theoretical and practical considerations.
    Rice GP
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):510-2. PubMed ID: 3315153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dantrolene in juvenile spasticity: 3 months of daily observation].
    Berruti P
    Riv Neurol; 1979; 49(1):30-52. PubMed ID: 451397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of cerebral palsy: subjectivity and a conundrum.
    Bodensteiner JB
    J Child Neurol; 1996 Mar; 11(2):75-76. PubMed ID: 8881980
    [No Abstract]   [Full Text] [Related]  

  • 20. The pharmacological management of spasticity.
    Saulino M; Jacobs BW
    J Neurosci Nurs; 2006 Dec; 38(6):456-9. PubMed ID: 17233517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.